Biogen Inc. buy Royal Bank of Canada
Start price
30.04.26
/
50%
€162.16
Target price
30.04.27
-
Performance (%)
13.10%
Price
09:53
€183.40
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 13.10%. This prediction currently runs until 30.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.033% | 2.033% |
| iShares Core DAX® | 0,88 % | 5,63 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % |
| iShares S&P 500 | 1,17 % | 2,55 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for BIIB provided by MarketBeat